WhitTier Trust Company’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.58M Sell
7,668
-55
-0.7% -$10.5K 0.03% 251
2026
Q1
$1.33M Buy
7,723
+15
+0.2% +$2.76K 0.03% 268
2025
Q4
$1.41M Sell
7,708
-13
-0.2% -$2.12K 0.03% 262
2025
Q3
$1.23M Sell
7,721
-25
-0.3% -$3.38K 0.03% 275
2025
Q2
$973K Hold
7,746
0.02% 315
2025
Q1
$1.06M Sell
7,746
-86
-1% -$12.3K 0.03% 298
2024
Q4
$1.2M Sell
7,832
-77
-1% -$13K 0.03% 272
2024
Q3
$1.53M Sell
7,909
-67
-0.8% -$14K 0.04% 248
2024
Q2
$1.85M Sell
7,976
-20
-0.3% -$4.35K 0.05% 224
2024
Q1
$1.72M Buy
7,996
+66
+0.8% +$15.5K 0.05% 235
2023
Q4
$2.05M Sell
7,930
-837
-10% -$206K 0.07% 217
2023
Q3
$2.25M Buy
8,767
+36
+0.4% +$9.63K 0.08% 194
2023
Q2
$2.49M Hold
8,731
0.08% 189
2023
Q1
$2.43M Buy
8,731
+191
+2% +$52.8K 0.09% 183
2022
Q4
$2.36M Sell
8,540
-12
-0.1% -$3.39K 0.09% 181
2022
Q3
$2.28M Sell
8,552
-150
-2% -$31.9K 0.1% 185
2022
Q2
$1.77M Buy
8,702
+93
+1% +$19K 0.07% 213
2022
Q1
$1.81M Hold
8,609
0.07% 222
2021
Q4
$2.06M Sell
8,609
-10
-0.1% -$2.57K 0.08% 202
2021
Q3
$2.44M Buy
8,619
+59
+0.7% +$19.3K 0.1% 168
2021
Q2
$2.96M Sell
8,560
-536
-6% -$162K 0.12% 151
2021
Q1
$2.54M Sell
9,096
-126
-1% -$34K 0.11% 154
2020
Q4
$2.26M Sell
9,222
-44
-0.5% -$11.4K 0.11% 162
2020
Q3
$2.63M Hold
9,266
0.15% 135
2020
Q2
$2.48M Sell
9,266
-402
-4% -$121K 0.16% 129
2020
Q1
$3.06M Buy
9,668
+18
+0.2% +$5.46K 0.24% 99
2019
Q4
$2.86M Sell
9,650
-294
-3% -$81.6K 0.18% 117
2019
Q3
$2.31M Sell
9,944
-3,499
-26% -$815K 0.16% 122
2019
Q2
$3.14M Sell
13,443
-819
-6% -$189K 0.22% 105
2019
Q1
$3.37M Buy
14,262
+29
+0.2% +$9.13K 0.25% 101
2018
Q4
$4.28M Buy
14,233
+84
+0.6% +$26.8K 0.35% 76
2018
Q3
$5M Buy
14,149
+65
+0.5% +$22.4K 0.36% 75
2018
Q2
$4.09M Buy
14,084
+115
+0.8% +$32.3K 0.32% 83
2018
Q1
$3.83M Sell
13,969
-2,023
-13% -$628K 0.31% 84
2017
Q4
$5.09M Buy
15,992
+265
+2% +$85K 0.44% 66
2017
Q3
$4.92M Buy
15,727
+14
+0.1% +$4.15K 0.46% 64
2017
Q2
$4.26M Sell
15,713
-33
-0.2% -$8.73K 0.41% 70
2017
Q1
$4.3M Buy
15,746
+264
+2% +$74.6K 0.43% 69
2016
Q4
$4.39M Buy
15,482
+8,013
+107% +$2.38M 0.47% 65
2016
Q3
$2.34M Sell
7,469
-243
-3% -$72K 0.27% 91
2016
Q2
$1.86M Sell
7,712
-36
-0.5% -$9.49K 0.21% 109
2016
Q1
$2.02M Sell
7,748
-635
-8% -$168K 0.24% 104
2015
Q4
$2.57M Buy
8,383
+925
+12% +$266K 0.3% 79
2015
Q3
$2.18M Buy
7,458
+6,458
+646% +$2.13M 0.27% 87
2015
Q2
$404K Buy
1,000
+125
+14% +$50.2K 0.04% 277
2015
Q1
$369K Hold
875
0.04% 291
2014
Q4
$297K Hold
875
0.03% 313
2014
Q3
$289K Hold
875
0.03% 298
2014
Q2
$276K Hold
875
0.03% 299
2014
Q1
$268K Hold
875
0.03% 300
2013
Q4
$245K Hold
875
0.03% 309
2013
Q3
$211K Hold
875
0.03% 317
2013
Q2
$188K Buy
+875
New +$187K 0.03% 320

Other funds holding BIIB

WhitTier Trust Company's BIIB Position: Q2 2026 in Review

WhitTier Trust Company reduced its Biogen (BIIB) stake by 0.71% in Q2 2026, selling an estimated $10.5K and leaving 7,668 shares worth $1.58M. The position accounts for 0.03% of the portfolio, ranked #251.

WhitTier Trust Company first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.09M in Q4 2017. 380 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • WhitTier Trust Company held 7,668 shares of Biogen worth $1.58M as of Q2 2026.
  • WhitTier Trust Company sold 55 Biogen shares in Q2 2026, an estimated $10.5K.
  • Biogen made up 0.03% of WhitTier Trust Company's portfolio in Q2 2026, its #251 holding.
  • WhitTier Trust Company first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
  • WhitTier Trust Company's Biogen position peaked at $5.09M in Q4 2017.
  • 380 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.